3Smith L E.Pathogenesis of retinopathy of prematurity[J].SeininNeona-tol,2003,8(6):469-473.
4Aiello L P,Avery R L,Arrigg P G,et al.Vascular endothelial growthfactor in ocular fluid of patients with diabetic retinopathy and other retinaldisorders[J].N England JMed,1994,6(331):1480-1487.
5Pierce E A,Avery R L,Fo ley E D,et al.Vascular endothelial growthfactor vascular permeability factor expression in a mouse model of retinalneovascularization[J].Proc Natl Acad Sci USA,1995,11 (92):905-909.
6Pierce E A,Foley E D,Smith L E.Regulation of vascular endothelialgrowth factor by oxygen in a model of retinopathy of prematurity[J].ArchOphthalmol,1996,114(10):1219-1228.
7Semenza G L.HIF-1 α:Using two hands to flip the angiogenic swtich[J].Cancer Metastasis Rev,2000,19(1-2):59-65.
8Risau W.Mechanisms of angiogenesis[J].Nature,1997,10(386):671-674.
10Robbins S G,Rajaratnam V S,Penn J S.Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors Fit-1 and Flk-1 in the oxygen-injured rat retina[J].Growth Factors,1998,16(1)1-9.
